Citadel Advisors - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 18 filers reported holding CYCLO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,075
-25.6%
14,137
-16.7%
0.00%
Q2 2023$26,997
+73.5%
16,979
-8.2%
0.00%
Q1 2023$15,55918,5010.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Renaissance Technologies 75,787$240,0000.00%
ROYAL BANK OF CANADA 746$2,0000.00%
VANGUARD GROUP INC 255,065$808,0000.00%
UBS Group AG 2,291$7,0000.00%
IFP Advisors, Inc 26$2,0000.00%
WELLS FARGO & COMPANY/MN 2,047$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 48,316$153,0000.00%
STATE STREET CORP 28,300$90,0000.00%
CITIGROUP INC 1,232$4,0000.00%
View complete list of CYCLO THERAPEUTICS INC shareholders